AI godfather and Turing Award winner Yoshua Bengio unveiled LawZero, a nonprofit dedicated to building “safe-by-design” AI systems
LawZero aims to create AI systems that provide probabilistic assessments rather than definitive answers, acknowledging uncertainty in their responses.
The organization's "Scientist AI" hopes to speed scientific development, monitor other AI agents for deceptive behaviors, and address AI risks
Bengio warns that current leading AI models, like o3 and Claude 4 Opus, show concerning traits including self-preservation instincts and strategic deception.
He also told FT that he doesn’t have confidence that OpenAI will adhere to its original mission, citing commercial pressures.
The U.S. Food & Drug Administration granted authorization for Clarity Breast, the first AI platform that can predict a woman's breast cancer risk from routine mammogram images, enabling a commercial launch for the preventative tool this year.